H&T Presspart is pleased to confirm our attendance at this year’s Respiratory Drug Delivery (RDD®) USA conference which will be held at the Omni Orlando Champions Gate, Orlando, Florida, from May 1st -5th, 2022.

During the conference H&T Presspart’s Richard Turner and Jacqueline Green will be hosting one of the signature workshops on Tuesday 3rd May entitled: ‘The future challenges facing metered-dose inhalers: Sustainability and the effective, efficacious delivery of complex molecules. ‘

The workshop aims to provide participants with a better understanding of the sustainability issues affecting the wider MDI industry and how device manufacturers can support the drive to sustainability through innovation and product development. Targeting the key factors of consistent dose delivery and performance, H&T Presspart will discuss how these innovations (Plasma canisters, Dose counting solutions) can also help to deliver complex drug formulations and drug mixtures to meet the market, patient and sustainability requirements of the industry.

Visitors to RDD USA will also be able to meet the H&T Presspart team in the exhibition hall, where we will be showcasing our full range of respiratory drug delivery components and devices, including our metered-dose inhaler canister and actuator range, as well as our dry powder inhaler and connected device portfolios.

During the exhibition, visitors to the H&T Presspart stand will also be able to learn more about the services and capabilities our New Product Development Centre and Inhalation Product Technology Centre offer and how we can support the design, development and manufacture of respiratory drug delivery devices.

If you would like to arrange a meeting with a member of our team during the conference then please contact us.